Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Owens & Minor to Acquire Apria in $1.45 Billion Deal

Published 01/10/2022, 03:30 PM
Updated 01/10/2022, 03:32 PM
© Reuters.

By Sam Boughedda

Investing.com — Shares of home healthcare equipment provider Apria Inc (NASDAQ:APR) rallied more than 25% Monday after global healthcare solutions business Owens & Minor Inc (NYSE:OMI) said it will acquire the company.

Owens & Minor will pay $37.50 in cash per share of Apria, representing a total value of approximately $1.45 billion. The price per share represents a 26% premium over Apria’s closing share price on Friday. In afternoon trading, its stock price is around the $37.44 level.

"The combination of two complementary businesses in Byram Healthcare and Apria will enable us to better serve the entire patient journey - through the hospital and into the home - ultimately furthering our mission of Empowering Our Customers to Advance Healthcare,” said Edward Pesicka, President & CEO of Owens & Minor. 

“In addition, this transaction diversifies our total company revenue stream by expanding our presence in the higher-growth home healthcare market.”

Owens & Minor outlined several reasons for the deal, such as strengthening the total company value proposition, diversifying its revenue base, and expanding its Patient Direct platform.

The deal is expected to close during the first half of 2022.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.